Eupraxia Pharmaceuticals (EPRX) Shares Outstanding (Diluted) (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Weighted Average Shares Outstanding (Diluted) of 39.96 million in Q2 2026, up 17.8% from 33.93 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Starting with Q4 2022, Eupraxia Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) history includes 15 quarters.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for three straight years, with a three-year compound annual growth rate of 27.5% (FY2022 to FY2025).
- Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 33.93 million in FY2024 (+40.5%), 24.15 million in FY2023 (+25.2%) and 19.29 million in FY2022.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 11 consecutive quarters, with growth averaging 30.1% over the last eight quarters.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 17.8% in Q4 2025 to 40.5% in Q3 2025.
- Per Business Quant, the preceding three quarters came in at 39.96 million (Q1 2026), 39.96 million (Q4 2025) and 33.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 39.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 39.96 Mn |
| Jun 30, 2026 | 39.96 Mn |
| Mar 31, 2026 | 39.96 Mn |
| Dec 31, 2025 | 39.96 Mn |
| Sep 30, 2025 | 33.93 Mn |
| Jun 30, 2025 | 33.93 Mn |
| Mar 31, 2025 | 33.93 Mn |
| Dec 31, 2024 | 33.93 Mn |
| Sep 30, 2024 | 24.15 Mn |
| Jun 30, 2024 | 24.15 Mn |
| Mar 31, 2024 | 24.15 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Sep 30, 2023 | 19.29 Mn |
| Jun 30, 2023 | 19.29 Mn |
| Mar 31, 2023 | 19.29 Mn |
| Dec 31, 2022 | 19.29 Mn |
API Access
Eupraxia Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();